Neoadjuvant Vemurafenib + Cobimetinib + Atezolizumab in Melanoma: NEO-VC
Clinical trial NCT02303951 · TERMINATED
Trial details
- NCT number
- NCT02303951
- Sponsor
- University Hospital Tuebingen
- Status
- TERMINATED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2015-01-22
- Primary completion
- 2020-05-14
- Enrollment
- 47
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.